Harlem Hosp Ctr — New York, New York

Harlem Hosp Ctr is a clinical research site located in New York, New York, United States 10037.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Harlem Hosp Ctr has participated in 31 clinical trials.

Therapeutic areas: HIV Infections, Bacterial Infections, Pneumonia, Pneumocystis Carinii.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Glaxo Wellcome, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Harlem Hosp Ctr?

Harlem Hosp Ctr has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Harlem Hosp Ctr conducted?

Harlem Hosp Ctr has 31 clinical trials on record. Their work covers HIV Infections, Bacterial Infections, Pneumonia, Pneumocystis Carinii.

Is Harlem Hosp Ctr accredited by Crixeo Health?

Yes — Harlem Hosp Ctr holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Harlem Hosp Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.